Вісник медичних і біологічних досліджень

[1] Global tuberculosis report 2022 [Internet]. [cited 2024 Apr 16]. Available from:https://iris.who.int/handle/10665/363752

[2] Lipman M, Cleverley J, Fardon T, Musaddaq B, Peckham D, van der Laan R, et al. Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK. BMJ Open Respir Res. 2020;7: 7:e000591. DOI: 10.1136/bmjresp-2020-000591 

[3] Gross JE, Caceres S, Poch K, Hasan NA, Jia F, Epperson LE, et al. Investigating nontuberculous mycobacteria transmission at the Colorado Adult Cystic Fibrosis Program. Am J Respir Crit Care Med. 2022;205(9):1064–74. DOI: 10.1164/rccm.202108-1911OC

[4] Alffenaar JW, Märtson AG, Heysell SK, Cho JG, Patanwala A, Burch G, et al. Therapeutic drug monitoring in non-tuberculosis mycobacteria infections. Clin Pharmacokinet. 2021;60(6):711–25. DOI: 10.1007/s40262-021-01000-6

[5] Gopalaswamy R, Shanmugam S, Mondal R, Subbian S. Of tuberculosis and non-tuberculous mycobacterial infections – a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci. 2020;27:74. DOI: 10.1186/s12929-020-00667-6

[6] Wu ML, Aziz DB, Dartois V, Dick T. NTM drug discovery: Status, gaps and the way forward. Drug Discov Today. 2018;23(8):1502–19. DOI: 10.1016/j.drudis.2018.04.001

[7] Drummond WK, Kasperbauer SH. Nontuberculous mycobacteria: Epidemiology and the impact on pulmonary and cardiac disease. Thorac Surg Clin. 2019;29(1):59–64. DOI: 10.1016/j.thorsurg.2018.09.006

[8] Pavlik I, Ulmann V, Weston RT. Clinical relevance and environmental prevalence of Mycobacterium fortuitum group members. Comment on Mugetti et al. Gene sequencing and phylogenetic analysis: powerful tools for an improved diagnosis of fish mycobacteriosis caused by Mycobacterium fortuitum group members. Microorganisms. 2021;9(11):2345. DOI: 10.3390/microorganisms9112345

[9] Zavgorodnii A, Bilushko V, Kalashnyk M, Pozmogova S, Kalashnyk N. Pseudo-allergic reactions to tuberculin in cattle. Vet Biotechnol. 2018;32:176–84.DOI: 10.31073/vet_biotech32(2)-20

[10] Turko I, Kulyaba O, Semanyuk V, Pelenyo R. Circulation of atypical mycobacteria in the environment and the organism as a cause of positive allergic reactions. Sci Mess Lviv Natl Univ Vet Med Biotechnol S Z Gzhytskyj. 2010;12(3-1):274–80.

[11] Boiko P, Nychyk S, Boiko O, Mandygra I. Some peculiarities of mycobacteriosis infectious and epizootic process in cattle caused by atypical acid-resistant mycobacteria. Vet Biotechnol. 2020;37:7–19. DOI: 10.31073/vet_biotech37-01

[12]  Bolaños CAD, Franco MMJ, Souza Filho AF, Ikuta CY, Burbano-Rosero EM, Ferreira Neto JS, et al. Nontuberculous mycobacteria in milk from positive cows in the intradermal comparative cervical tuberculin test: Implications for human tuberculosis infections. Rev Inst Med Trop Sao Paulo. 2018;60. DOI: 10.1590/s1678-9946201860006

[13] Busol V, Boiko P, Bednarski M, Shevchuk V, Mazur V. Pathomorphological changes in the organs of the peripheral immune system in mycobacteriosis of cattle. Ukr J Vet Sci. 2023;14(2):9–27. DOI: 10.31548/veterinary2.2023.09

[14] Todoriko L, Shevchenko O. Modern aspects of pulmonary mycobacteriosis (analytical review). Act Infectol. 2022;(4.13):13–21. DOI: 10.22141/2312-413x.4.13.2016.91449

[15] Kumar K, Loebinger MR. Nontuberculous mycobacterial pulmonary disease: Clinical epidemiologic features, risk factors, and diagnosis: the nontuberculous mycobacterial series. Chest. 2022;161(3):637–46. DOI: 10.1016/j.chest.2021.10.003

[16] Shin JI, Shin SJ, Shin MK. Differential genotyping of Mycobacterium avium complex and its implications in clinical and environmental epidemiology. Microorganisms. 2020;8(1):98. DOI: 10.3390/microorganisms8010098

[17] Zhurilo O, Barbova A, Sladkova L. Mycobacterium avium as pathogen of human mycobacteriosis. Ukr Pulmonol J. 2020;1:50–58. DOI: 10.31215/2306-4927-2020-107-1-50-58

[18] Merritt RW, Walker ED, Small PLC, Wallace JR, Johnson PDR, Benbow ME, et al. Ecology and transmission of Buruli ulcer disease: A systematic review. PLoS Negl Trop Dis. 2010;4(12). DOI: 10.1371/journal.pntd.0000911

[19] Thomson RM, Furuya-Kanamori L, Coffey C, Bell SC, Knibbs LD, Lau CL. Influence of climate variables on the rising incidence of nontuberculous mycobacterial (NTM) infections in Queensland, Australia 2001-2016. Sci Total Environ. 2020;740:139796. DOI: 10.1016/j.scitotenv.2020.139796

[20] Daley CL, Griffith DE. Pulmonary non-tuberculous mycobacterial infections. Int J Tuberc Lung Dis. 2010;14(6):665–71.

[21] Zhurilo O, Barbova A. Modern state and prospects of diagnostics of lung diseases caused by nontuberculous mycobacteria. Tuberc Lung Dis HIV Infect. 2019;1:73–80.

[22] Aubry A, Mougari F, Reibel F, Cambau E. Mycobacterium marinum. Microbiol Spectr. 2017;5(2). DOI: 10.1128/microbiolspec.TNMI7-0038-2016

[23] Strollo SE, Adjemian J, Adjemian MK, Prevots DR. The burden of pulmonary nontuberculous mycobacterial disease in the United States. Ann Am Thorac Soc. 2015;12(10):1458–64. DOI: 10.1513/AnnalsATS.201503-173OC

[24]  Yarchuk B, Verbytskyi P, Lytvyn V, Kornienko L, Litvin V, Kornienko L, et al. General epizootiology. Bila Tserkva; 2002. 656 p.

[25]  Peters M, Müller C, Rüsch-Gerdes S, Seidel C, Göbel U, Pohle HD, Ruf B. Isolation of atypical mycobacteria from tap water in hospitals and homes: Is this a possible source of disseminated MAC infection in AIDS patients? J Infect. 1995;31(1):39–44. DOI: 10.1016/s0163-4453(95)91333-5

[26]  Falkinham JO 3rd. Nontuberculous mycobacteria in the environment. Clin Chest Med. 2002;23(3):529–51. DOI: 10.1016/s0272-5231(02)00014-x

[27]  Shevchenko O, Todoriko L, Poteyko P, Pogorelova O. Issues of diagnosis and treatment of non-tuberculous mycobacteriosis. Diagn Infect Dis. 2019;1(10):36–53. DOI: 10.15407/internalmed2019.01.036

[28] Tran QT, Han XY. Subspecies identification and significance of 257 clinical strains of Mycobacterium avium. J Clin Microbiol. 2014;52. DOI: 10.1128/jcm.03399-13

[29] Falkinham JO 3rd, Norton CD, LeChevallier MW. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other mycobacteria in drinking water distribution systems. Appl Environ Microbiol. 2001;67(3):1225–31. DOI: 10.1128/AEM.67.3.1225-1231.2001

[30] Furuuchi K, Morimoto K, Yoshiyama T, Tanaka Y, Fujiwara K, Okumura M, et al. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan. Respir Med. 2019;152:74–80. DOI: 10.1016/j.rmed.2019.05.001

[31] Ko RE, Moon SM, Ahn S, Jhun BW, Jeon K, Kwon OJ, et al. Changing epidemiology of nontuberculous mycobacterial lung diseases in a Tertiary Referral Hospital in Korea between 2001 and 2015. J Korean Med Sci. 2018;33(8):e65. DOI: 10.3346/jkms.2018.33.e65

[32] Tan Y, Su B, Shu W, Cai X, Kuang S, Kuang H, Liu J, Pang Y. Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016. BMC Pulm Med. 2018;18:168. DOI: 10.1186/s12890-018-0728-z

[33] Velayati AA, Rahideh S, Nezhad ZD, Farnia P, Mirsaeidi M. Nontuberculous mycobacteria in the Middle East: Current situation and future challenges. Int J Mycobacteriol. 2015;4(1):7–17. DOI: 10.1016/j.ijmyco.2014.12.005

[34] Shrivastava K, Kumar C, Singh A, Narang A, Giri A, Sharma NK, et al. An overview of pulmonary infections due to rapidly growing mycobacteria in South Asia and impressions from a subtropical region. Int J Mycobacteriol. 2020;9(1):62–70. DOI: 10.4103/ijmy.ijmy_179_19

[35] Norton GJ, Williams M, Falkinham JO 3rd, Honda JR. Physical measures to reduce exposure to tap water–associated nontuberculous mycobacteria. Front Public Health. 2020;8:190. DOI: 10.3389/fpubh.2020.00190

[36] Marras TK, Campitelli MA, Lu H, Chung H, Brode SK, Marchand-Austin A, et al. Pulmonary nontuberculous mycobacteria-associated deaths, Ontario, Canada, 2001-2013. Emerg Infect Dis. 2017;23(3):468–76. DOI: 10.3201/eid2303.161927

[37] Smith GS, Ghio AJ, Stout JE, Messier KP, Hudgens EE, Murphy MS, et al. Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010. J Infect. 2016;72(6):678–86. DOI: 10.1016/j.jinf.2016.03.008

[38] Carneiro MDS, Nunes LS, David SMM, Dias CF, Barth AL, Unis G. Nontuberculous mycobacterial lung disease in a high tuberculosis incidence setting in Brazil. J Bras Pneumol. 2018;44(2):106–11. DOI: 10.1590/s1806-37562017000000213

[39] Prevots DR, Marshall JE, Wagner D, Morimoto K. Global epidemiology of nontuberculous mycobacterial pulmonary disease: A review. Clin Chest Med. 2023;44(4):675–21. DOI: 10.1016/j.ccm.2023.08.012

[40] Panagiotou M, Papaioannou AI, Kostikas K, Paraskeua M, Velentza E, Kanellopoulou M, et al.. The epidemiology of pulmonary nontuberculous mycobacteria: Data from a general hospital in Athens, Greece, 2007-2013. Pulm Med. 2014;2014:894976. DOI: 10.1155/2014/894976 

[41] Blanc P, Dutronc H, Peuchant O, Dauchy FA, Cazanave C, Neau D, et al. Nontuberculous mycobacterial infections in a French hospital: A 12-year retrospective study. PLoS One. 2016;11(12):e0168290. DOI: 10.1371/journal.pone.0168290

[42] Przybylski G, Bukowski J, Kowalska W, Pilaczyńska-Cemel M, Krawiecka D. Trends from the last decade with nontuberculous mycobacteria lung disease (NTM-LD): Clinicians’ perspectives in Regional Center of Pulmonology in Bydgoszcz, Poland. Pathogens. 2023;12(8):988. DOI: 10.3390/pathogens12080988

[43] Rindi L, Garzelli C. Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014. BMC Infect Dis. 2015;16:44. DOI: 10.1186/s12879-016-1380-y

[44] Modrá H, Ulmann V, Caha J, Hübelová D, Konečný O, Svobodová J, et al. Socio-economic and environmental factors related to spatial differences in human non-tuberculous Mycobacterial diseases in the Czech Republic. Int J Environ Res Public Health. 2019;16(20):3969.DOI: 10.3390/ijerph16203969

[45] Davies BS, Roberts CH, Kaul S, Klein JL, Milburn HJ. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London. Scand J Infect Dis. 2012;44(11):815–19. DOI: 10.3109/00365548.2012.694469

[46] Zomer D, van Ingen J, Hofland R; Dutch CF Registry Steering group. Epidemiology and management of nontuberculous mycobacterial disease in people with cystic fibrosis, the Netherlands. J Cyst Fibros. 2023;22(2):327–33. DOI: 10.1016/j.jcf.2022.10.009

[47] Aliyu G, El-Kamary SS, Abimiku A, Brown C, Tracy K, Hungerford L, Blattner W. Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria. PLoS One. 2013;8(5). DOI: 10.1371/journal.pone.0063170

[48] Buijtels PC, van-der-Sande MA, de-Graaff CS, Parkinson S, Verbrugh HA, Petit PL. Nontuberculous mycobacteria, Zambia. Emerg Infect Dis. 2009;15(2):242–49. DOI: 10.3201/eid1502.080006  

[49] Okoi C, Anderson STB, Antonio M, Mulwa SN, Gehre F, Adetifa IMO. Non-tuberculous mycobacteria isolated from pulmonary samples in sub-Saharan Africa: A systematic review and meta-analyses. Sci Rep. 2017;7:12002. DOI: 10.1038/s41598-017-12175-z